Sanofi pays Nurix $15M upfront for autoimmune degrader
03 Apr 2025 //
PRESS RELEASE
Public health group sue over $1.1B in revoked funds
03 Apr 2025 //
FIERCE BIOTECH
FDA taps insider Scott Steele to lead CBER on acting basis
03 Apr 2025 //
FIERCE PHARMA
Roche`s high-dose version of Ocrevus flunks phase 3 trial
03 Apr 2025 //
FIERCE PHARMA
Novo nearly doubles earnings as Wegovy swells coffers
03 Apr 2025 //
REUTERS
Indian pharma stocks `breathe easy` on US tariffs exemption
03 Apr 2025 //
REUTERS
Marubeni grabs Sumitomo`s Asia pharma business in $480M deal
03 Apr 2025 //
FIERCE PHARMA
FDA misses deadline for decision on Novavax`s vaccine
03 Apr 2025 //
REUTERS
Novartis receives FDA accelerated approval for Vanrafia
03 Apr 2025 //
PR NEWSWIRE
Drugs In Development

Market Intel
